National Institute Of Neurological Disorders And Stroke (ninds)
Clinical trials sponsored by National Institute Of Neurological Disorders And Stroke (ninds), explained in plain language.
-
Cancer drug tested to fight long COVID's brain fog and fatigue
Disease control Not yet recruitingThis early-stage study is testing whether a single dose of pembrolizumab, a drug used for cancer, is safe for people with long-term neurological symptoms after COVID-19. Researchers want to see if the drug can help reset the immune system and improve symptoms like fatigue, thinki…
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for deadly brain cancer: experimental drug enters human trials
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LMP744 in adults whose aggressive brain cancer (glioblastoma) has returned after standard treatment. The main goal is to see if the drug can shrink tumors and slow the cancer's progression. Participants will receive the drug thr…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
Early trial tests 'Ultra-Hot' pepper compound to numb severe cancer pain
Symptom relief Not yet recruitingThis early-stage study is testing whether an experimental injection called resiniferatoxin (RTX) is safe and can reduce severe, untreatable pain caused by cancer that has spread to the bones. Up to 30 adults who have not found relief from standard pain medications will receive a …
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated Mar 16, 2026 15:25 UTC